Jane Zheng

Jane Zheng is a prominent inventor based in San Diego, CA. She has made significant contributions to the field of RNA interference (RNAi) technology. With a total of 3 patents, her work focuses on developing innovative solutions for gene modulation.

Latest Patents

One of her latest patents involves SiRNA structures designed for high activity and reduced off-target effects. This invention provides compounds, compositions, and methods for modulating the expression of target genes using RNA interference. The RNAi structures and molecules developed by Zheng can effectively modulate or silence gene expression, achieving high levels of RNAi activity while minimizing off-target actions. Notably, advantageous structures include siRNAs targeted to any gene that contains one or more 2′-deoxy nucleotides located in the seed region. These RNA interference molecules hold promise for use in methods aimed at preventing or treating various diseases.

Career Highlights

Jane Zheng is currently associated with Nitto Denko Corporation, where she continues to advance her research and innovations in RNAi technology. Her work has garnered attention for its potential applications in therapeutic interventions.

Collaborations

Some of her notable coworkers include Kenjirou Minomi and Jens Harborth, who contribute to her research endeavors and collaborative projects.

Conclusion

Jane Zheng's contributions to RNA interference technology exemplify her innovative spirit and dedication to advancing scientific knowledge. Her patents reflect her commitment to developing effective solutions for gene modulation and disease treatment.

This text is generated by artificial intelligence and may not be accurate.